These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 3387522)
1. An open-label, dose-finding study of WY-45,030, a novel bicyclic antidepressant. Schweizer E; Clary C; Weise C; Rickels K Psychopharmacol Bull; 1988; 24(1):195-7. PubMed ID: 3387522 [No Abstract] [Full Text] [Related]
2. Efficacy and safety of b.i.d. doses of venlafaxine in a dose-response study. Mendels J; Johnston R; Mattes J; Riesenberg R Psychopharmacol Bull; 1993; 29(2):169-74. PubMed ID: 8290661 [TBL] [Abstract][Full Text] [Related]
3. An open-label, variable-dose study of WY-45,030 (venlafexine) in depressed outpatients. Goldberg HL; Finnerty R Psychopharmacol Bull; 1988; 24(1):198-9. PubMed ID: 3387523 [No Abstract] [Full Text] [Related]
4. Venlafaxine: loss of antidepressant effect and its management. Sharma V J Clin Psychiatry; 1998 Jul; 59(7):381-2. PubMed ID: 9714268 [No Abstract] [Full Text] [Related]
5. Venlafaxine--a new antidepressant. Med Lett Drugs Ther; 1994 Jun; 36(924):49-50. PubMed ID: 8196569 [No Abstract] [Full Text] [Related]
12. [Effect of carbamazepine combined with an ineffective antidepressant. Apropos of 4 cases]. Navarre C; Maurin C; Colonna L Encephale; 1994; 20(1):79-80. PubMed ID: 8174514 [No Abstract] [Full Text] [Related]
13. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study. Amsterdam JD; Shults J J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727 [TBL] [Abstract][Full Text] [Related]
14. Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness. Hannan N; Hamzah Z; Akinpeloye HO; Meagher D J Psychopharmacol; 2007 Mar; 21(2):161-4. PubMed ID: 17329295 [TBL] [Abstract][Full Text] [Related]
15. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients. Mendels J; Reimherr F; Marcus RN; Roberts DL; Francis RJ; Anton SF J Clin Psychiatry; 1995; 56 Suppl 6():30-6. PubMed ID: 7649971 [TBL] [Abstract][Full Text] [Related]
16. Rate of non-adherence prior to upward dose titration in previously stable antidepressant users. Muzina DJ; Malone DA; Bhandari I; Lulic R; Baudisch R; Keene M J Affect Disord; 2011 Apr; 130(1-2):46-52. PubMed ID: 20950862 [TBL] [Abstract][Full Text] [Related]
17. [Open preliminary study of new antidepressive compound: citalopram]. Ropert R; Lôo H; Gay C Encephale; 1984; 10(3):131-4. PubMed ID: 6594229 [TBL] [Abstract][Full Text] [Related]
18. Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression. Baune BT; Caliskan S; Todder D Hum Psychopharmacol; 2007 Jan; 22(1):1-9. PubMed ID: 17191266 [TBL] [Abstract][Full Text] [Related]
19. [Not neglecting therapy of depression in the elderly]. MMW Fortschr Med; 2006 Apr; 148(16):56-7. PubMed ID: 16688953 [No Abstract] [Full Text] [Related]
20. [Patch testing increases the likelihood of recognizing lamotrigine as a cause of drug-induced rash]. Fuertes L; García-Cano I; Ortiz de Frutos J; Vanaclocha F Actas Dermosifiliogr; 2011 Jan; 102(1):64-6. PubMed ID: 21315866 [No Abstract] [Full Text] [Related] [Next] [New Search]